Your Environment. Your Health.

Skip Navigation

IMACS Publications

  1. Charles-Schoeman C, Amjadi SS, Paulus HE; International Myositis Assessment and Clinical Studies Group, Treatment of dyslipidemia in idiopathic inflammatory myositis: results of the International Myositis Assessment and Clinical Studies Group survey, Clin Rheumatol, 2012 Aug 31(8): 1163-8. Epub 2012 Apr 21[Abstract ]

     

  2. Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, Herbelin L, Barohn R, Isenberg D, Miller FW, Measures of Adult Dermatomyositis, Polymyositis and Inclusion Body Myositis, Arthritis Care and Research2011 63: S118-S157[Abstract ]

     

  3. Rider LG, Lachenbruch PA, Monroe JB, Ravelli A, Cabalar I, Feldman BM, Villalba ML, Myones BL, Pachman LM, Rennebohm RM, Reed AM, Miller FW; IMACS Group, Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index, Arthritis Rheum, 2009 Nov 60(11):3425-35[Pub Med ]

     

  4. Dugan EM, Huber AM, Miller FW, and Rider LG, Photoessay of the idiopathic inflammatory myopathies, Dermatology Online Journal, 2009 15(2):1[Dermatology Online Journal ]

     

  5. Dugan EM, Huber AM, Miller FW, and Rider LG, Review of the cutaneous manifestations of the idiopathic inflammatory myopathies, Dermatology Online Journal, 2009 15(2):2[Dermatology Online Journal ]

     

  6. Rider LG, Lachenbruch P, Isenberg DA, Miller FW, Applicability of the paediatric rheumatology international trials organisation disease activity core set for juvenile dermatomyositis: comment on the article by Ruperto et al., Arthritis Rheum, 2008 Aug 15 59(8):1197-8[Pub Med ]

     

  7. Oddis CV, Rider LG, Reed AM, Ruperto N, Brunner HI, Koneru B, Feldman BM, Giannini EH, Miller FW, International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies, Arthritis Rheum, 2005 Sep 52(9):2607-2615[Pub Med ]

     

  8. Rider LG, Giannini EH, Brunner HI, Ruperto N, James-Newton L, Reed AM, Lachenbruch PA, Miller FWInternational Myositis Assessment and Clinical Studies Group, International Consensus On Preliminary Definitions of Improvement for Adult and Juvenile Myositis, Arthritis Rheum, 2004 Jul 50(7):2281-90[Pub Med ]

     

  9. Rider LG, Giannini EH, Harris-Love M, Joe G, Isenberg D, Pilkington C, Lachenbruch PA, Miller FWInternational Myositis Assessment and Clinical Studies Group, Defining Clinical Improvement in Adult and Juvenile Myositis, J Rheumatol, 2003 Mar 30(3):603-17[Pub Med ]

     

  10. Isenberg DA, Allen E, Farewell V, Ehrenstein M, Hanna MG, Lundberg IE, Oddis C, Pilkington C, Plotz P, Scott D, Venkovsky J, Rider L, Miller F.for the International Myositis and Clinical Studies Group (IMACS), International consensus outcome measures for patients with idiopathic inflammatory myopathies: Development and initial validation of myositis activity and damage indices in patients with adult onset disease, Rheumatology (Oxford), 2003 42: 1 - 7[Pub Med ]

     

  11. Rider LGInternational Myositis Outcome Assessment Collaborative Study Group, Outcome assessment in the adult and juvenile idiopathic inflammatory myopathies, Rheum Dis Clin North Am, 2002 Nov 28(4):935-77[Pub Med ]

     

  12. Miller FW, Rider LG, Chung YL, Cooper R, Danko K, Farewell V, Lundberg I, Morrison C, Oakley L, Oakley I, Pilkington C, Vencovsky J, Vincent K, Scott DL, Isenberg DA, Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies, Rheumatology (Oxford), 2001 Nov 40(11):1262-73[Pub Med ]

Back to Top